Cover Image

Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti.

In order to guarantee the fulfillment of their complex lifecycle, adult filarial nematodes release millions of microfilariae (MF), which are taken up by mosquito vectors. The current strategy to eliminate lymphatic filariasis as a public health problem focuses upon interrupting this transmission thr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kathrin Arndts (Author), Susanne Deininger (Author), Sabine Specht (Author), Ute Klarmann (Author), Sabine Mand (Author), Tomabu Adjobimey (Author), Alexander Y Debrah (Author), Linda Batsa (Author), Alexander Kwarteng (Author), Christian Epp (Author), Mark Taylor (Author), Ohene Adjei (Author), Laura E Layland (Author), Achim Hoerauf (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2012-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
by: Kathrin Arndts, et al.
Published: (2014)

Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment.
by: Manuel Ritter, et al.
Published: (2019)

Hyperreactive onchocerciasis is characterized by a combination of Th17-Th2 immune responses and reduced regulatory T cells.
by: Gnatoulma Katawa, et al.
Published: (2015)

Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes.
by: Ulrich F Prodjinotho, et al.
Published: (2017)

Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
by: Jonathan Mnkai, et al.
Published: (2022)

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.
by: Sarah E Greene, et al.
Published: (2022)

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections
by: Sarah E. Greene, et al.
Published: (2022)

Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection.
by: Joseph Kubofcik, et al.
Published: (2012)

Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.
by: Anandharaman Veerapathran, et al.
Published: (2009)

Wuchereria bancrofti infection is linked to systemic activation of CD4 and CD8 T cells.
by: Inge Kroidl, et al.
Published: (2019)

An analysis of genetic diversity and inbreeding in Wuchereria bancrofti: implications for the spread and detection of drug resistance.
by: Thomas S Churcher, et al.
Published: (2008)

Detection of Wuchereria bancrofti in the city of São Luís, state of Maranhão, Brazil: New incursion or persisting problem?
by: Tatiane Alexandre de Araújo, et al.
Published: (2023)

Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti.
by: Katy L Hamlin, et al.
Published: (2012)

COVID-19 unfolding filariasis: The first case of SARS-CoV-2 and Wuchereria bancrofti coinfection.
by: Mouhand F H Mohamed, et al.
Published: (2020)

Interruption of lymphatic filariasis transmission in Manaus, a former focus of Wuchereria bancrofti in the Western Brazilian Amazon
by: Marilaine Martins, et al.
Published: (2021)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India.
by: Abhishek Kumar Singh, et al.
Published: (2023)

Molecular xenomonitoring for Wuchereria bancrofti in Culex quinquefasciatus in two districts in Bangladesh supports transmission assessment survey findings.
by: Seth R Irish, et al.
Published: (2018)

A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
by: Cédric B Chesnais, et al.
Published: (2017)

Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.
by: Samuel Wanji, et al.
Published: (2019)

Detection of Wuchereria bancrofti L3 larvae in mosquitoes: a reverse transcriptase PCR assay evaluating infection and infectivity.
by: Sandra J Laney, et al.
Published: (2010)

Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history.
by: Scott T Small, et al.
Published: (2013)

A randomized controlled trial of increased dose and frequency of albendazole with standard dose DEC for treatment of Wuchereria bancrofti microfilaremics in Odisha, India.
by: Shantanu Kumar Kar, et al.
Published: (2015)

Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
by: Shantanu K Kar, et al.
Published: (2017)

Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial.
by: Ute Klarmann-Schulz, et al.
Published: (2017)

Integrated xenosurveillance of Loa loa, Wuchereria bancrofti, Mansonella perstans and Plasmodium falciparum using mosquito carcasses and faeces: A pilot study in Cameroon.
by: Joseph Pryce, et al.
Published: (2022)

Identification and characterization of a novel nematode pan allergen (NPA) from Wuchereria bancrofti and their potential role in human filarial tropical pulmonary eosinophilia (TPE).
by: Samuel Christopher Katru, et al.
Published: (2024)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
by: Constant Edi, et al.
Published: (2019)

Morbidity management and surveillance of lymphatic filariasis disease and acute dermatolymphangioadenitis attacks using a mobile phone-based tool by community health volunteers in Ghana.
by: Linda Batsa Debrah, et al.
Published: (2020)

Kolaviron shows anti-proliferative effect and down regulation of vascular endothelial growth factor-C and toll like receptor-2 in Wuchereria bancrofti infected blood lymphocytes
by: Aliyu Muhammad, et al.
Published: (2017)

Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana.
by: Derrick Adu Mensah, et al.
Published: (2022)

Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test.
by: Housseini Dolo, et al.
Published: (2019)

Molecular xenomonitoring of diurnally subperiodic Wuchereria bancrofti infection in Aedes (Downsiomyia) niveus (Ludlow, 1903) after nine rounds of Mass Drug Administration in Nancowry Islands, Andaman and Nicobar Islands, India.
by: Addepalli Premkumar, et al.
Published: (2020)

Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model.
by: Sabine Specht, et al.
Published: (2018)

Seroprevalence and Risk Factors of Toxoplasma gondii Infection among Pregnant Women in Kumasi: A Cross-Sectional Study at a District-Level Hospital, Ghana
by: Bhavana Singh, et al.
Published: (2021)

Active infection with Onchocerca volvulus and the linkage to epilepsy/nodding syndrome.
by: Kathrin Arndts, et al.
Published: (2024)

Active infection with Onchocerca volvulus and the linkage to epilepsy/nodding syndrome
by: Kathrin Arndts, et al.
Published: (2024)

Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
by: Joseph D Turner, et al.
Published: (2010)

Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.
by: Kawsar R Talaat, et al.
Published: (2015)

Immunization with L. sigmodontis microfilariae reduces peripheral microfilaraemia after challenge infection by inhibition of filarial embryogenesis.
by: Sebastian Ziewer, et al.
Published: (2012)

Mansonella perstans microfilaremic individuals are characterized by enhanced type 2 helper T and regulatory T and B cell subsets and dampened systemic innate and adaptive immune responses.
by: Manuel Ritter, et al.
Published: (2018)